The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

N Engl J Med. 2009 Dec 3;361(23):2204-7. doi: 10.1056/NEJMp0910479. Epub 2009 Nov 2.

Authors

Debra Birnkrant¹, Edward Cox

Affiliation

¹ Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

PMID: 19884645
DOI: 10.1056/NEJMp0910479

No abstract available

MeSH terms

Acids, Carbocyclic
Antiviral Agents / therapeutic use*
Cyclopentanes / therapeutic use*
Drug Approval*
Drugs, Investigational / therapeutic use*
Emergencies
Enzyme Inhibitors / therapeutic use
Guanidines / therapeutic use*
Humans
Influenza A Virus, H1N1 Subtype*
Influenza, Human / drug therapy*
Injections, Intravenous
Investigational New Drug Application
Neuraminidase / antagonists & inhibitors*
United States
United States Food and Drug Administration

Substances

Acids, Carbocyclic
Antiviral Agents
Cyclopentanes
Drugs, Investigational
Enzyme Inhibitors
Guanidines
Neuraminidase
peramivir